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EFFECTIVENESS, EFFICIENCY AND EQUITY 
Helmut Wenzel 
 
 
 
THEORETICAL BACKGROUND 
Introduction 
Health is perceived as most precious good, and people feel its vulnerability. Societies have 
been trying to absorb, ameliorate or compensate consequences and health risks with 
varying emphasis and varying success. Due to the uniqueness of good health to a persons’ 
ability to live the life he or she wants, health care and performance of health care systems 
are under critical observation. In this context many discussions swivel around ethics, 
justice, equity, equality and fairness, very often using these notions interchangeably. 
Sometimes they are used as arguments to challenge every economic consideration by 
claiming “the freedom of therapeutic choices”, and pointing out the humanitarian aspect of 
an individual’s health and the danger of withholding intervention options or rationing. It is 
not surprising to see, that many health care professionals and patients see a certain 
incompatibility between financing, operational aspects of health care, like allocation of 
resources, and ethical expectations. Nevertheless, this is not necessarily so. In the 
following we will discuss what principles should rule a health care system. Furthermore 
conflicts and trade-offs between performance measures like effectiveness and efficiency 
and equity considerations will be discussed. 
 The provision of health care takes place in a complex system (see figure 1). In the 
framework for producing health, the citizen’s health or patient’s outcomes are determined 
by several factors. It is quite obvious that primarily the configuration of the existing 
structure of the care environment and the processes by number and quality make up the 
frame of action and finally determine the patient’s outcomes. Nevertheless, the state of the 
art of medicine, training, education, and last but not least the financial resources define the 
portfolio of feasible interventions. Thus, the organization of health care, e.g. financing, and 
provision of care is a limiting variable in this context which deserves specific attention. 
The set-up of the health care system is critical to an appropriate and feasible care.  
In Western economies health economists think that a suitable organizational make-up of a 
health care system should fulfil the following criteria (1): 
− Sovereignty and personal responsibility of citizens; 
− So-called secondary liability of state-run actions; 
− Equity (horizontally and vertically); 
− Effectively and efficiency; 
− Sustainability and stability; 
− Legal certainty; 
− Transparency. 
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Figure 1: Determinants of Health Care. Source: Helmut Wenzel, unpublished 
 
Besides criteria that pick out more or less aspects of self-conception and self-
determination - like sovereignty, personal responsibility, and elements of performance, e.g. 
stability - effectiveness and efficiency are seen to be equally important. Furthermore, we 
expect that the access to health care and the available care should not be limited by the 
social standing or financial potential. Limited resources and its usage always raise 
questions of justice. Equity considerations are therefore inseparably linked to fair processes 
of resource allocation. The relative importance (weights) of the various criteria might be 
different in different societies. They have to be seen in the light of a societal consensus - a 
kind of societal treaty. In this treaty it is laid down how a society is made up. Basically 
important considerations have to be made with respect to the questions whether the societal 
self-conception is socialistic, communistic or more liberal. Is the governance autocratic or 
more democratic? And finally is the economy based on free-market or more regulated? 
Depending on the combination of the above features, the expectation on the quality of a 
health care system might vary substantially. Anyhow, questions will come up like, what 
health services should be publicly funded, how indications for particular interventions 
should be defined, whether societal groups need specific attention and how.  
Researchers from different scientific disciplines have been working on justice, ethics 
or equity in health care with various tools, paradigms and intentions. Philosophers (2) with 
the view on justice and ethics came to a similar appraisal as economists who specify 
criteria for an appropriate health care system. However, the philosophers’ view is more 
focused on the “direct” human needs and consequences. Justice is understood here as an 
equivalent of normative ethics, and the way how moral topics are analyzed. It describes 
primarily a set of tools and methods (3). They conclude that four principles should be the 
basis for an ethical evaluation of health care, independent from the make-up of the system. 
They are seen as a kind of normative guidance. Those principles are (1) respect for 
autonomy, (2) beneficence, (3) non-mal-efficiency and (4) justice. Researchers with focus 
on 'medical ethics', aiming specifically at regulating the relationship between patient and 
health care professional, have been specifying six principles that should guide the 
behaviour of an ethical doctor. These principles are: (a) preserve life, (b) alleviate 
  
4 
suffering, (c) do no harm, (d) tell the truth, (e) respect the autonomy of the patient and (f) 
deal fairly with patients.  
None of these principles are absolute or independent; each may conflict with the 
others. There might even exist trade-offs which are quantity-dependent. Hence, the binding 
character of those principles is “prima facie”, which means that the binding is unless it 
conflicts with another moral principle. If it does, one has to choose between them (4). The 
resolution of such conflicts is a matter of personal value judgment. Unfortunately, 
philosophers don’t provide a method for this kind of appreciation and for solving value 
conflicts. Following Samuelson’s definition of economics this is the typical domain of 
economics and health economics. He states” the study of how men and society end up 
choosing, with or without the use of money, to employ scarce productive resources that 
could have alternative uses, to produce various commodities and distribute them for 
consumption, now or in the future, among various people and groups in society. It analyses 
the costs and benefits of improving patterns of resource allocation (5). 
 
 
Equity and Ethics  
As mentioned earlier, fairness, justice and equity are notions that are often used syno-
nymously to describe concerns about access to health care and the amount of care citizens 
will get without discrimination. The Office of Health Economics (OHE) outlines this 
concern as follows: “Efficiency is not everything. We are also concerned with what is fair. 
If we had a market distribution of health care, then only those who could afford to pay 
would be able to purchase it. Most people regard that as unacceptable. This is a major 
reason why most societies regard health care as different from other commodities”.  
Questions regarding equity have been the main reason for government involvement 
in health care world-wide. OHE further states “A concern about equity was one of the main 
motivating forces behind the creation of the National Health Service (NHS) in the UK. 
William Beveridge, the architect of the welfare state, argued for a health service which 
would provide treatment "to every citizen without exception, without remuneration limit 
and without an economic barrier at any point to delay recourse to it". Equity has remained 
a major goal within the UK system. A concern about equity has also been reflected by 
other countries' approaches to health care. McGuire, Henderson and Mooney have pointed 
out that the introduction of public health insurance in Canada in 1971 "was explicitly 
stated to be motivated by a concern to make health care utilization less dependent upon 
income". Blewett has suggested that in Australia "The introduction of Medicare in 
February 1984 was designed to ensure that all Australians have access to medical and 
hospital services on the basis of need". Even in the US, which has the most market 
orientated health care system in the developed world, the state intervened to provide 
Medicare and Medicaid to help the poor afford health care”(6). 
 
The Content of Equity 
Looking at literature, there seems to be no uniquely correct way of defining equity and its 
determination. Mooney for example listed seven possible definitions: Equality of 
expenditure per capita, inputs per capita, inputs for equal need, access for equal need, 
utilization for equal need, marginal met need, and health. He finally comes to the con-
clusion that a mix of equal inputs for equal need and equal access for equal need might be 
the most practical (feasible) description of equity (7).  
WHO refers to equity as “principle of being fair to all, with reference to a defined 
and recognized set of values”. More concretely it says “equity in health implies that ideally 
everyone should have a fair opportunity to attain their full health potential and more 
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pragmatically, that no one should be disadvantaged from achieving this potential, i.e. 
everyone should have geographical and financial access to available resources in health 
care ...” (8). The crux with this statement is that it establishes a relation between the 
undetermined notion “equity” and the undetermined notion “fair opportunity”.    
A more illustrative definition comes from Mayberry et al. stating equity means to 
“provide care that does not vary in quality because of personal characteristics such as 
gender, ethnicity, geographic location, and socioeconomic status” (9). 
For further considerations it turned out to be useful to distinguish between horizontal 
and vertical equity. Horizontal equity means equal treatment for equal conditions; it 
applies especially to the delivery of health care, e.g. equal resources, utilization, and access 
per head. Most discussions refer to this. In this case, the efficiency and equity aspects will 
tend to move together. Nevertheless, most conflicts are seen in vertical equity. Vertical 
equity deals with the question whether unequal cases are treated unequally. In prevention 
one could think about a case where for a majority of a population the risk could be reduced 
a little and would save fewer lives than concentrating the same resources on a few at high 
risk. The case could be even more delicate when we assume that the few are at higher ages. 
Another example, if there was a rare blood type of which the hospital only has access to 
one unit of blood, and they at the same time receive two patients who both need one unit of 
that rare blood. One of them is a 22 year old recent college graduate who was in an 
accident with a drunk driver, and the other is an 80 year old widower, who has been sick 
for 5 years. Representatives of a “fair innings” approach (10) would say that we should 
give the unit to the 22 year old because there is more life to be lived by him than the sick 
80 year old man. Another case with ethnically grounded disparities and conflicts between 
efficiency and equity deals with kidney transplants. The efficiency of transplantation could 
be improved by human leukocyte antigens (HLA) matching. The closer the match the 
better is the chance of a successful transplant. From the viewpoint of using scarce 
resources efficiently this matching makes sense. Gaston et al (11) found out that this policy 
discriminates black patients for whom it is less likely to find a match. They conclude that 
for the sake of equity diminished efficiency has to be accepted.  
 
 
The Philosophical Basis of Equity  
Even when we refer to the universal principles mentioned earlier the application of moral 
rules comes to different results. Obviously, the definition of equity and its practical use 
depends on the underlying, not always overt - philosophical theories. To understand 
ongoing discussions and solutions offered in the literature one has to come back to the 
philosophical theories. The different schools can be classified into: Utilitarianism, 
Rawlsian, Entitlement/libertarian, Egalitarian, Deontological, Virtue and “Rights” 
oriented theories. 
Each of them has a specific focus. The underlying concept of utilitarianism is 
maximizing for the greatest utility for greatest number. This is compatible with economic 
efficiency considerations. Critical question is whose utilities are meant? The Rawlsian 
position expects an allocation conducted under a ‘veil of ignorance’, aiming at balancing 
between higher and lower risk in people who are discriminated by nativity (Rawls, 1971). 
“Veil of ignorance” means that a principle of allocation would be called just, when people 
would agree on the principles in a situation where they don’t know whether they are sick 
and whether they would benefit from the principle. In fact this theory assumes total risk 
averseness, and leads to a position of less well off in society being maximized. 
Entitlement/libertarian (Robert Nozick, 1974) holds the view that individuals are entitled 
to get what they have acquired “justly” within a market situation. Emphasis is put on 
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freedom of choice and property rights, assuming minimal state involvement. This is similar 
to utilitarianism. Moral rules as a strict guiding principle play the central role in 
deontological and virtue based theories. Moral rules like ‘do to others as you would have 
done to you’ (Kant), depict an absolute moral code of how life should be lived. Rights 
based theories focus on indisputable ‘rights’ which cannot be overridden, e.g. ’right’ to 
life. They are absolute and inflexible. 
According to their main focus they also can be divided into theories that deal 
primarily with distributive justice, highlighting fairness of outcomes and those that look at 
procedural justice concerned with the processes in achieving the outcomes. Figure 2 gives 
an overview.  
 
 
Figure 2: Categories of Ethical Theories. Source: Health Economics Network UK 
 
The definition of equity is as multifarious as the heterogeneity of philosophical 
theories. Which philosophical concept is appropriate for a given health care system and 
which definition of equity should be chosen depends on the societal consensus. Even when 
we accept that the four ethical rules are universal, the application of ethics to practical 
decision-making is very much guided by the expectation of a society. A kind of lowest 
denominator is the criterion of equality of access which is consistent with most ethical 
theories and consistent with efficiency (it preserves consumer sovereignty). 
 
Guidance for Analyzing Equity in Health Care 
Disparities may occur at different parts of a network. At the level of the health care system, 
at an individual and community level and, last but not least, on a patient-provider level. 
Mayberry et al. propose a theoretical framework for the analysis of disparities. Figure 3 
shows those parts of a kind of influence network. Indicators of inequality are access, use 
and health outcomes. 
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Figure 3: Three Dimensions of an Influence Network of Inequalities. Source: Based on 
Mayberry (9) 
 
The individual/environment entity covers factors like socio-cultural norms and 
values, social network and cohesions, and individual health promotion and care-seeking 
behaviour. The patient-provider part focuses on communication between patients and 
provider. This includes factor as trust, respect, patient participation in clinical decisions 
and ability to navigate the health care system. Finally, the capacity of the health care 
system is put on a test-bench. This is, in a narrow sense, the classical topic for analyzing 
equity.  
The basic practical problem facing an equity policy is to find out which patients are 
the worst-off and should receive priority. Practically it is not easy to determine the degree 
of inequality. Rutten even stimulates the creation of an aggregate measure of expected 
misery (12). At least, on a national or regional level disparities can be determined by 
calculating measures of statistical dispersion like a Gini Index or a Suits Index, to display 
disparities in financing or health.  
 
Economics in Health Care: Compatibility or inexpiable Polarity 
Many clinicians and citizens don’t feel comfortable with economically grounded assess-
ments. They believe that allowing costs to influence clinical decisions is unethical. They 
are mistaken in this belief. It cannot be ethical to ignore the adverse consequences upon 
others of the decisions you make, which is what 'costs' means from an economist’s view. 
Of course, there are some important ethical issues in deciding what costs to count, and how 
to count them. But these dilemmas are equally strong with respect to what benefits to count 
and how to count them, some of which expose ethically untenable assumptions about such 
widely-used clinical criteria as survival rates. One of the advantages of systematic 
economic appraisal tools, like cost-effectiveness analysis is that it exposes these hidden 
assumptions, and requires explicit judgments to be made about which ethical position is 
appropriate in a particular policy context. By creating transparency this should have the 
important incidental benefit of improving the accountability of policy-makers to the 
community they are serving (13).  
In opposition to these cited conflicts economists should have no difficulty in 
seeing their own work in the health care field as being directed towards the 
fulfilment of those same ethical principles. According to their professional 
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terminology they would probably name it differently. Williams points out that, for 
instance, the demand to preserve life and alleviate suffering would be seen as a description 
of the objectives of health care, concentrating our attention on improving both the length 
and quality of people's lives. The postulation to do no harm would be seen as a request to 
minimize the risks of adverse effects from treatment and even as a plea for prevention. 
Telling the truth is a general duty accepted by all analysts, and respecting the autonomy of 
the patient would be seen as referring to the need to have the patients' values count rather 
than those of the practitioners when decisions about treatment are being made. But the 
final item on the list - about dealing fairly with patients - reminds us that we will seldom 
find ourselves dealing with situations in which only one patient's interests are affected, so 
that we will have to face the problematical question of how much weight to attach to the 
(possibly conflicting) values of each affected individual in such circumstances. And in any 
system in which the individual patient pays only part of the costs of care, the number of 
individuals who are affected in one way or another by a treatment decision may be very 
large indeed (14). 
Consequently, economists have been trying to overcome the vagueness and high 
level argumentation by breaking down those principles into applicable principles, 
processes and tools. The health economist is seeking, through the use of appraisal 
techniques to help decision-makers to maximize the benefits of health care within the 
constraint of whatever level of resources society has chosen to devote to health care. These 
benefits are seen as improvements in people's length and quality of life in which the 
distribution of these benefits between individuals is a matter of some importance. Clearly, 
there is nothing there that conflicts with conventional medical ethics. Even the stress laid 
by economists on the need to examine carefully the 'trade-offs' that are established at the 
margin between the competing good things that we seek in health care, simply mirrors the 
relativity of ethical principles and the acknowledged need to strike a balance between 
them. The difficulties seem to arise because economists go further than others do in the 
quantification of these elements. We must now explore why they do so, and for this 
purpose adopt a somewhat different perspective, that of welfare economics (14). 
Williams explains that economists have sought to avoid making explicit inter-
personal comparisons when judging whether one situation is better or worse than another, 
and a whole branch of the subject - i.e. 'welfare economics' - has grown from that 
ambitious objective. The basic idea is to separate 'efficiency' from 'equity', with 'efficiency' 
being kept free of interpersonal comparisons of welfare, all such judgments being 
encompassed in 'equity'. The definition of efficiency which achieves this separation is due 
to Pareto (and hence is often called Pareto-efficiency) and it declares a situation to be 
efficient if in that situation it is not possible to make anyone better off without making 
someone else worse off. If resources are being used 'wastefully' it should be possible to put 
them to some other use which will not harm the person from whom they are taken but will 
benefit those to whom they are given, thus the initial situation would have been 
'inefficient'. The same would generally be true if resources are lying idle or are 
underutilized. 
In the Paretian framework it is the individual's own judgment of whether he or she is 
better or worse off that counts, not the judgment of any third party; thus it observes very 
strictly the ruling to respect the autonomy of the individual. No judgments are made about 
the status quo, which is simply accepted as the starting point, our only concern being 
whether or not some change is an unambiguous improvement on it. The realm of 
application of this strict Paretian notion of 'efficiency' is, however, severely limited, since 
there are very few changes in real life that do not adversely affect the welfare of somebody 
or other. To ease this restriction on the applicability of the strict efficiency criterion, it was 
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extended to cover situations in which the potential gainers from a change could fully 
compensate the potential losers, and still have some gains left over (compensation being 
paid in money terms, say). But identifying actual gainers and losers precisely, and setting 
up an incorruptible mechanism to enable such compensation actually to be paid, would in 
most cases be very costly. So this 'compensation principle' in turn got watered down to 
include cases where the compensation did not actually have to be paid, thus under the 
'potential Pareto criterion' it has only to be shown that for a change to be declared 
'efficient' the gains must on balance outweigh the losses (gains and losses generally being 
evaluated in money terms). To decide whether gains outweigh losses they must be 
measured in commensurable terms, so there has grown up a strong tradition of 
quantification and valuation, which has been applied to all kinds of gains and losses, 
including the value of life and safety. Calculating the 'efficiency' gains and losses in this 
way still leaves us with the distributional consequences to think about, and these are 
typically transferred to the 'equity' realm to be evaluated separately. In practice they are 
often ignored, however, in the hope that in the long run, over a multitude of different 
activities, they will all wash out. Thus the efficiency calculus as used in practice by 
economists does not really achieve the desired avoidance of all interpersonal comparisons 
of welfare. At best it says there are no losers, and it assumes that it does not matter who the 
gainers are. At worst it says that there are both gainers and losers, but it is up to somebody 
else to look at the equity implications (15). 
 
Dealing with Limited Resources 
No health care system can satisfy all the possible demands made upon it, so decisions 
about allocating resources are of particular importance. The allocation takes place at 
different levels: i.e. allocation between institutions and by type of care. For instance 
decisions have to be made about the amount of money that should be devoted to hospitals, 
even different kind of hospitals, and how much money should go to ambulatory care. 
Those decisions are very often overlapped by regional or municipal considerations that lay 
outside the health care sector and the appropriate provision of care. There are connections 
to other sectors of a national economy and respective goals, like strengthening the regional 
economic performance. 
 
 
 
 
Figure 4: Alternative Ways of allocating limited Resources. Based on: J. Coast et al (15) 
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Even more complex are decisions that have to allocate money between the different 
kinds of prevention, cure and rehabilitation. Again, facing the fact that resources will 
always be limited, the question is how this task can be achieved in a way that satisfies most 
of the expectations of modern, democratic societies. According to Coast (15) more or less 
two options exist: Rationing and explicit priority setting. 
Rationing is a crucial issue, sometimes it is even misunderstood. Health care 
rationing refers to “any planning, resource allocation or pruning of ineffective or unproved 
processes” (16, 17). Rationing is thus merely another term for stating that we must decide 
how to allocate our limited resources (18). Much rationing takes place by controlling the 
access to the health care system. It is not only debatable who is entitled (or authorized) to 
make these decisions. It is also critical how the rationing procedure looks like and what are 
the relevant criteria and who defined it. In an implicit rationing procedure the decisions and 
the preferences are not revealed, which is hardly acceptable in modern societies. There is 
no real awareness of the principles used. In contrast, explicit rationing is concerned with 
making clear the decisions that have been made and the basis upon which the decisions 
have been made. It results from political bargaining processes and/or technical methods as 
promoted by economist. In political processes the consent of society could be received by 
either lay participation in the decision processes or by the anticipation of the citizen needs 
by experts. In the late sixties this kind of effort to integrate as many citizens with their 
specific needs as possible in political planning processes was called advocacy planning. 
The basic and progressive idea was that experts (and politicians) would be able and willing 
to anticipate the problems of those people that have not the ability to participate in political 
processes in a democratic appropriate way. In reality this approach was not very successful 
and should not be seen as a significant option. In contrast economists rely on the “art” of 
making rational choices and promote that choices should be made more explicit and be 
based on efficiency appraisals (19).   
Looking at the very nature of health economics the starting point is straightforward, 
“In the beginning, middle and end was, is, and will be scarcity of resources” (20), and the 
issue of choice and priorities. Taking a choice - priority setting means that a decision has to 
be made not only about what to do, but also what to leave undone. Opportunities forgone - 
what we leave undone - is central to health economics. Opportunities forgone are cost: 
“The cost of a unit of a resource is the benefit that would be derived from using it in its 
best alternative use.” (21) The concept of cost in health economics is different to the 
concept of cost in accounting that relates to cash outlays. Therefore, when economists 
argue that attention should be paid to efficiency in health care they are implying that health 
care programmes, treatments and procedures should be compared not only in terms of their 
relative benefits, but also in terms of their relative costs, i.e. benefits forgone. 
 
 
The Concept of Efficiency 
The concept of efficiency is central to the models and techniques proposed by economists. 
Economic theory believes in the rational nature of men (paradigm of homo oeconomicus). 
This further leads to the assumption that each individual wants to maximize its degree of 
satisfaction, which is measured in terms of benefits. In order to maximize the benefits the 
individual will make sure that the last unit of money spent will create the same amount of 
benefit. Efficiency can be classified into different forms: 
1. Technical efficiency, with two sub forms: 
a) Cost-efficiency: Product applications or intervention strategies which achieve a 
given health outcome at the lowest level of resource utilization are called 
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efficient or economical. This is also called operational efficiency and 
sometimes cost-effectiveness (22). It refers to the so-called fixed effectiveness 
approach, too. 
b) Output-efficiency: Product applications or intervention strategies which 
generate the best possible outcome or goal achievement for a given resource 
input are called efficient or most productive. This is also called fixed cost 
approach. 
2. Allocative efficiency 
 Looks at the combination of goods that have to be financed and goes beyond 
looking for the most cost-effective types of interventions. This could mean that 
what conditions should be treated is subject to evaluation as well. The 
theoretical foundation is the definition of efficiency of Pareto (so called Pareto-
efficiency). A situation is perceived to be efficient if it is not possible to make 
anyone better off without making someone else worse off. 
 
Efficiency evaluations include an assessment of resource input (or costs) and 
outcomes. Generally speaking, efficiency is measured by the relationship between the level 
of accomplishment of these goals (consequences) and the resources used or expenditures. 
The fact that something is efficient does not necessarily mean that it will lead to cost 
reduction; cost reduction and efficiency generally represent two different perspectives. An 
intervention can be called efficient when an additional resource input or higher cost are 
required to achieve a better outcome with a higher, overcompensating benefit.  
Therefore, even those interventions which are more expensive than established 
alternatives, but which exhibit higher performance of medical tests in terms of predictive 
value, greater effectiveness in treatments/interventions, more safety, fewer side-effects, etc. 
may be efficient.  
Whereas private accounting is generally limited to factors measurable in monetary 
terms, classical economic analysis extends the examination to qualitative and intangible 
costs and consequences. It explicitly attempts to measure factors which are difficult to 
evaluate monetarily. Statements regarding the relative economic efficiency of intervention 
strategies compared require an examination of the entire spectrum of costs and 
consequences of interventions.  
There are different ways to define and to measure benefits. Some of those methods 
are based on the principles of welfare-theory, some are based on the assumption only that 
men are deciding in a rational way (pragmatic decision-makers). Other methods 
incorporate the preferences of patients into the desirability of outcomes.  Table 1 gives a 
short overview. 
The appropriate choice of a method depends not only on the availability of data; it 
rather has to be guided by the purpose of the assessment. Insofar scientific strictness is the 
guiding principle. The various stakeholders have different views and goals (see figure 5). 
The usage of the results determines the viewpoint and consequently the number of effects 
measured and the way how they are valued. Health economics literature describes three 
different perspectives an analyst can take when determining the cost and benefits of a 
health program: welfarist, extra-welfarist and pragmatic (decision-maker oriented). Each 
of those perspectives have specific objectives, are based on different principles and 
assumptions, values the costs and benefits differently and therefore demands specific data. 
A welfarist has a strong welfare economics theoretical background. He puts considerable 
emphasis on the valuation from an individual’s viewpoint, thus preferring the willingness-
to-pay method or the method of prevailed preferences to the human capital approach. A 
pure perspective of the health sector budget holder is taken by the extra-welfarist. 
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The pragmatist’s view theoretically is the weakest. Choosing the appropriate 
evaluation approach not only depends on the problem being addressed, but also on the 
institutional framework and the measurement challenges (24). Within the scope of the 
operationalization of an evaluation project one must crosscheck the research question with 
the specific attention and motives of stakeholders and subsequently find the relevant 
outcome measures and criteria of economic performance and the respective evaluation 
method. Finally one has to cover topics like level of evidence needed, the economic criteria 
and the decision rules to be applied.  
 
 
 
Table 1. Study Types and Goals 
Type of Study  Goal 
Cost-
Minimization 
Analysis 
Determine the least expensive intervention strategy for accomplishing 
the same medical outcomes. 
Cost-
Effectiveness 
Analysis 
Determine the more efficient intervention strategy for accomplishing 
the same type of medical results in terms of cost per medical outcome 
measures (cost per life years gained).  
Cost-Utility 
Analysis 
Determine the more efficient intervention strategy for accomplishing 
the same type of medical results in terms of cost per constructed 
summarizing unit of outcome (cost per Quality-Adjusted Life Years). 
Cost-Benefit 
Analysis 
Assessment in money terms of whether an intervention strategy is 
efficient, i.e. worth doing, and comparison with alternative 
intervention strategies to determine which is ‘most’ efficient.  
Cost-
Consequence 
Analysis 
Determine a listing of the medical and economic consequences of 
alternative interventions - used to indicate their consequences without 
summarizing. 
Cost-of – Illness Determine of the cost of illness - used to indicate the need for 
treatment or the potential economic benefits from improved 
intervention strategies. 
Quality-of-Life 
Study 
Relative assessment of intervention strategies regarding patient health 
outcome. The health outcome is measured by disease specific health 
status parameters or general quality of life instruments. 
Source: Wenzel H, Hysa B. Economic Appraisal as a Basis for Decision Making in Health 
Care (23) 
 
 
Effectiveness and Efficiency 
Efficiency can be seen as the final stage of a logical process of three steps measuring 
economic performance from efficacy to effectiveness and finally to efficiency (see figure 
4). Without efficacy and without effectiveness no efficiency is possible. Efficacy and 
effectiveness both describe to what extend a goal could be reached. If a goal cannot be 
reached, any resource input is wasted and therefore inefficient. Historically effectiveness 
measurements come from engineering science where technical performance had to be 
measured. The result has been typically displayed as physical units per resource used. In 
the health care sector for example cost per saved years of life or prevented cases. The 
measure of effectiveness can be multidimensional. This can lead then to challenges when 
making the comparison with and without a project. For that reason analyst always try to 
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have one outcome measure either by finding an algorithm to aggregate the various 
indicators into one measure or by applying measures that are multidimensional, like a 
quality of life measurement scale.  Cost-Utility Analysis (CUA) specifically takes this into 
consideration. 
 
 
 
Figure 5: Medical and Economic Benefits from different Viewpoints. Source: Wenzel, 
Presentation at EDMA meeting in Brussels, 2008 
 
Efficacy is a specific measure of effectiveness used in the health care sector. 
Efficacy is the study outcome under ideal, i.e. controlled conditions and is expected to be 
an unbiased proof that an intervention works. It is a “proof of principle”, based on 
randomized clinical trials (RCT). Controlling for possible confounders implicates that 
compliance is higher than in real life and the patients are highly selected (exclusion of 
certain conditions, i.e. multi-morbidity, age and gender) and therefore not representative 
for a specific target population. Transferring efficacy data directly to a target population 
would lead to an overestimation of the effects. As a next step one wants to know now how 
it works under real conditions in a target population. This kind of evaluation provides 
effectiveness data. It is the classical area for empirical studies of health services research 
and public health. If efficacy and effectiveness are proven, efficiency analysis would be the 
final step, then. As efficiency depends on the health care system, the viewpoint of the 
evaluation and therefore on the number of effects and assessed data of efficacy and 
effectiveness do not necessarily lead to efficient results.  
 In summary on can say, that efficacy and effectiveness data are prerequisites, and in 
terms of formal logic, essential but not sufficient conditions. It happens that effective 
interventions are useful and efficient in one country but not in others. One has to be 
cautious to transfer (uncritically) data between various countries. The study types shown in 
the table above will deliver different kinds of information that might not be suitable for any 
research question. A cost-effectiveness analysis (CEA) will only display relative 
efficiency, i.e. compare only two alternatives aiming at the same objective. Therefore 
many economists express their concerns whether a CEA is suitable for comparing across 
different forms of health care (allocative efficiency) thus providing technical efficiency 
only. A cost-benefit analysis (CBA) displays absolute efficiency, like in a business 
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investment calculation, where the return of investment is calculated. The valuation of life 
(saves years of life) in terms of money has been disputed for many reasons. Equity issues 
are seen in way how the valuation of saved cases of different ages are weighted or how life 
and health will be valued. Nevertheless, there are many ways to carry out a CBA. The 
valuation of physical units, like saved years of life, can be based on willingness-to-pay or 
on the human capital approach. With the willingness-to-pay approach the preferences of 
citizens or patients are used to put a monetary value on time. From an economic 
perspective this is the adequate way. 
 
Figure 6: Medical and Economic Performance from different Viewpoints. Source: 
Presentation at EDMA meeting in Brussels, 2008 
 
In practice there is much preparatory work required. With the human capital 
approach lifetime is valued based on the earnings of person that are either forgone or could 
be saved when life is prolonged and/or morbidity is prevented. It has been a challenge to 
value lifetime of pensioners, housewives and children in an acceptable way. In spite of 
that, this approach has some advantages with respect to feasibility (availability of data). In 
addition to the question whether a type of valuation is in line with the evaluation goal and 
the design, it is the human capital approach that contributed to the disrepute of economic 
evaluations and raised ethical questions. 
 
 
Conclusion  
In conclusion one can say that the request for efficiency and inherently effectiveness and 
for equity has the same roots: It is scarcity. So, efficiency and equity are flip sides of a 
coin. Equity without efficiency is not feasible, and efficiency without taking equity into 
consideration is unethical. There is no universal agreed ethics for objectives of the health 
care sector. But equality of access is consistent with most ethical theories and consistent 
with efficiency - it preserves consumer sovereignty.  
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EXERCISES 
Task 1. 
After introductory lectures students will work in small groups divided according to their 
countries. They will be given the case study to discuss the question of equity and 
effectiveness in a health system. This exercise should take 45 minutes.  
 
Task 2. 
For the next exercise, they will be grouped in two larger groups, the first group will be pro 
equity oriented and the second group pro efficiency oriented. They will participate in 
debate (pro equity vs. pro efficiency). The aim of the discussion is to explore the 
possibilities for change and improvement of equity and efficiency in their case study health 
system. The exercise will be concluded with discussion summary given by teacher. It is 
recommended that exercise lasts 90 minutes.  
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